Voyageur Pharmaceuticals Ltd (VM.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13 | 250 | 2 | 2 | 124 |
| Receivables | 27 | 18 | 36 | 27 | 44 |
| Inventories | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $176 | $449 | $89 | $96 | $224 |
| Non-Current Assets | |||||
| PPE Net | 2,136 | 2,098 | 2,061 | 2,064 | 2,010 |
| Other Non-Current Assets | 14 | 14 | 14 | 14 | 14 |
| TOTAL | $2,150 | $2,112 | $2,075 | $2,078 | $2,024 |
| Total Assets | $2,326 | $2,562 | $2,164 | $2,174 | $2,248 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $1,024 | $931 | $674 | $428 | $399 |
| Non-Current Liabilities | |||||
| Long Term Debt | 40 | 40 | 40 | 26 | 26 |
| Other Non-Current Liabilities | 14 | 14 | 14 | 14 | 14 |
| TOTAL | $54 | $54 | $54 | $40 | $40 |
| Total Liabilities | $1,078 | $985 | $728 | $468 | $439 |
| Shareholders' Equity | |||||
| Common Shares | 9,149 | 9,153 | 8,690 | 8,684 | 8,684 |
| Retained earnings | -10,019 | -9,457 | -9,128 | -8,845 | -8,724 |
| Other shareholders' equity | 13 | 13 | 12 | 0 | 0 |
| TOTAL | $1,248 | $1,576 | $1,436 | $1,706 | $1,809 |
| Total Liabilities And Equity | $2,326 | $2,562 | $2,164 | $2,174 | $2,248 |